Children's self-reports on perceived effects on taking stimulant medication for ADHD
Lisa B Thorell1, Kerstin Dahlström
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Lisa.Thorell@psyk.uu.se
Objective:
This study investigates children's views on positive and negative effects of stimulant medication for ADHD and the children's willingness to stop taking medication.
Method:
Questionnaire data were collected from 79 children with ADHD and one of each child's parents.
Results/Conclusion:
Swedish children treated with stimulants generally experienced positive treatment effects in many areas, especially in the school setting, and a majority wished to continue taking their medication. There was, however, a small group of children who reported a relatively large number of negative effects. Few differences between parents and children were found for positive effects, although parents reported higher levels of negative effects. Results also indicate that the child's knowledge of why he or she is on stimulant medication and the parent's views of medication are important factors to take into consideration as they influence the child's willingness to continue his or her medication.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Self-Evaluation: Self-Enhancement and Self-Verification
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
The Placebo Effect


